London-based private equity firm 3i has reportedly sold its venture portfolio to an unnamed bidder for around £100m, a substantial discount to the approximate £250m book value.
Managing director Craig Ferguson discusses accelerated deployment activity during the pandemic and plans to scale up the PE allocation by 2025
Fund has a target of $600m, which it plans to reach by next year, according to Kommersant
Existing investors including Institut Català de Finances also take part in the financing
Biotech company initially raised €12m in December 2018